EKF Diagnostics (LON:EKF) Stock Crosses Below Two Hundred Day Moving Average – What’s Next?
by Teresa Graham · The Cerbat GemEKF Diagnostics Holdings plc (LON:EKF – Get Free Report)’s share price passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 27.35 and traded as low as GBX 24.47. EKF Diagnostics shares last traded at GBX 25, with a volume of 2,800,593 shares traded.
EKF Diagnostics Trading Up 1.6%
The company has a fifty day simple moving average of GBX 27.36 and a two-hundred day simple moving average of GBX 27.35. The company has a market capitalization of £110.59 million, a P/E ratio of 18.52 and a beta of 0.57. The company has a debt-to-equity ratio of 0.34, a current ratio of 4.60 and a quick ratio of 1.77.
EKF Diagnostics (LON:EKF – Get Free Report) last issued its quarterly earnings data on Tuesday, September 16th. The company reported GBX 0.43 EPS for the quarter. EKF Diagnostics had a return on equity of 7.03% and a net margin of 9.37%. On average, analysts forecast that EKF Diagnostics Holdings plc will post 2.2987842 earnings per share for the current fiscal year.
About EKF Diagnostics
EKF is an AIM-listed global diagnostics business focussed on:
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
Further Reading
- Five stocks we like better than EKF Diagnostics
- Manufacturing Stocks Investing
- Keysight Technologies’ Surge: The Market Wakes Up to This AI Play
- There Are Different Types of Stock To Invest In
- Is American Express the Credit Stock For a K-Shaped Economy?
- The 3 Best Retail Stocks to Shop for in August
- Powering Up: How a Credit Upgrade Fuels Vistra’s AI Ambitions